Inactive Instrument
Aoxing Pharmaceutical Company Inc Share Price NYSE
Stocks
US03740A1060
Professional & Business Education
OTC Markets Traded| Market Cap | 23.62M 20.44M 19.08M 17.51M 32.93M 2.25B 33.45M 224M 87.88M 1.13B 88.72M 86.77M 3.73B | P/E 2015 |
20.1x | P/E 2016 | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 42.18M 36.49M 34.08M 31.26M 58.8M 4.01B 59.73M 400M 157M 2.01B 158M 155M 6.65B | EV / Sales 2015 |
5.77x | EV / Sales 2016 | 2.11x |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | -28.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chun Fai Lo
CEO | Chief Executive Officer | - | - |
Po Chim
DFI | Director of Finance/CFO | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.29% | -4.31% | - | - | 1.33M | |
| -0.92% | +1.90% | -26.87% | -52.22% | 1.96B | |
| +2.44% | +4.30% | - | - | 1.88B | |
| +3.88% | -26.35% | +7.78% | +260.97% | 1.6B | |
| +4.22% | -1.98% | +72.59% | +359.01% | 1.3B | |
| 0.00% | -4.73% | -48.82% | +38.06% | 1.23B | |
| +0.76% | +0.12% | +330.04% | +915.03% | 1.11B | |
| +1.90% | +15.57% | +44.08% | +90.63% | 1.03B | |
| +0.95% | -2.29% | +57.15% | +42.43% | 1.01B | |
| +5.02% | +30.53% | +73.45% | -18.44% | 686M | |
| Average | -1.00% | +0.37% | +63.67% | +204.43% | 1.31B | |
| Weighted average by Cap. | +1.83% | -1.15% | +51.86% | +198.36% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 25.48M 22.04M 20.58M 18.88M 35.51M 2.43B 36.08M 241M 94.78M 1.22B 95.69M 93.59M 4.02B | 32.33M 27.97M 26.12M 23.96M 45.06M 3.08B 45.78M 306M 120M 1.54B 121M 119M 5.1B |
| Net income | 5.49M 4.75M 4.44M 4.07M 7.66M 523M 7.78M 52.07M 20.44M 262M 20.63M 20.18M 867M | 2.06M 1.78M 1.67M 1.53M 2.87M 196M 2.92M 19.53M 7.67M 98.33M 7.74M 7.57M 325M |
| Net Debt | 24.8M 21.46M 20.04M 18.38M 34.57M 2.36B 35.12M 235M 92.27M 1.18B 93.15M 91.11M 3.91B | 18.56M 16.05M 14.99M 13.75M 25.87M 1.77B 26.28M 176M 69.04M 885M 69.7M 68.17M 2.93B |
Employees
-
